Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
Approval
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…
Clinical
FDA advisory panel split on whether to approve Durect’s Posimir for…
Approval
Breast cancer patients to have further NICE-approved drug combination option on…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…
Deals
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…
Commercial
US judge hacks $8-billion damages verdict against Johnson & Johnson in…
Deals
JPM Day 3: High Prices in San Francisco Are a Problem,…
Home
Commercial
Merger
Merger
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merger
CoImmune Inc., a US-based clinical-stage biotech, and Formula Pharmaceutical Inc. agree to merge in an all-stock transaction
Firstwordpharma News
-
January 16, 2020
Merger
Mergers: Commission approves AbbVie’s acquisition of Allergan, subject to conditions
Merger
Galecto and PharmAkea Merge to Create Strong Clinical-Stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer
Merger
Following Antitrust Concerns, Illumina and Pacific Bio Call Off $1.2 Billion Merger
Merger
BridgeBio Pharma Terminates Merger Process With Its Subsidiary Eidos Therapeutics
Merger
Emmaus Life Sciences Completes Merger
Biospace News
-
July 17, 2019
0
Merger
Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex...
Firstwordpharma News
-
June 25, 2019
0
Merger
Gyroscope Therapeutics merges with Orbit Biomedical creating a leading retinal gene...
-
April 12, 2019
0
Merger
Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed...
-
April 8, 2019
0
Merger
X4 Pharmaceuticals Completes Merger with Arsanis
Firstwordpharma News
-
March 13, 2019
0
1
2
Page 1 of 2
- Advertisement -
MOST POPULAR
Bayer and Dewpoint Therapeutics Ink $100 Million Research Partnership
November 15, 2019
Servier and UCL collaborate in fight against immune-inflammatory diseases
December 10, 2019
Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for...
June 24, 2019
InDex Pharmaceuticals Holding AB (publ) Year end Report 2018
February 20, 2019
Load more
HOT NEWS
Phase III
Almirall Announces Late-Breaking Oral Presentation of KX2-391 Ointment in Two Phase...
Orphan-paediatric
3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo for Ear Reconstruction...
Others
CORRECTING and REPLACING Noveome Biotherapeutics, Inc. Announces the First Patient Dosed...
Commercial
Ardelyx to Participate in Leerink Partners 8th Annual Global Healthcare Conference
